Bios Health Group has entered into the life science market as a strategic partner providing services for life science companies and investors. The company will offer strategies to attract funding, optimize clinical development and create commercial strategies. Bios Health Group also serves as a venture partner providing investor preparation for biotech companies seeking investment funding and access to Venture funds through its investor networks.

Bios Health’s four strategic solutions include:

• BioInvest offers life science companies guidance on investment preparation including business plans, investor attractive investment pitches and access to investor networks. 
• Innovate Bio focuses on clinical development optimization, prioritizing R&D indications, and pipelines to help maximize value leveraging innovations, strategic and patient-centric approaches to optimize and accelerate clinical development.
• CRO Select provides services to help Biotech companies save time and money as they make the crucial decision of selecting the right fit Clinical Research Organization.
• LaunchMax offers commercial strategy development and execution to help maximize success. In addition, the BIOS Innovation Circle brings together strategic experts to provide tailored solutions.

Bios Health Group CEO Zizi Uzezi Imatorbhebhe, said, “We are thrilled to bring this comprehensive suite of end-to-end solutions to Biotech and Life Science companies. Our strategic approach involves engagement with Venture Capitalists and Investors, effectively addressing the funding gap that often impedes early-stage Biotech companies from accessing critical financial resources required to realize their innovative concepts. Additionally, we provide established companies with proven commercial strategies to launch new products and expand their market presence”.